S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
AAPL   318.73 (+1.11%)
FB   222.14 (+0.17%)
MSFT   167.10 (+0.56%)
GOOGL   1,479.52 (+2.02%)
AMZN   1,864.72 (-0.70%)
CGC   24.89 (+2.43%)
NVDA   249.28 (+0.14%)
BABA   227.43 (+1.56%)
MU   57.66 (-0.03%)
GE   11.81 (-0.25%)
TSLA   510.50 (-0.58%)
AMD   50.93 (+2.33%)
T   38.38 (+0.92%)
ACB   2.13 (-0.93%)
F   9.16 (-0.11%)
NFLX   339.67 (+0.31%)
PRI   128.43 (+0.05%)
BAC   34.71 (-0.03%)
GILD   62.98 (-0.35%)
DIS   144.33 (-0.54%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
AAPL   318.73 (+1.11%)
FB   222.14 (+0.17%)
MSFT   167.10 (+0.56%)
GOOGL   1,479.52 (+2.02%)
AMZN   1,864.72 (-0.70%)
CGC   24.89 (+2.43%)
NVDA   249.28 (+0.14%)
BABA   227.43 (+1.56%)
MU   57.66 (-0.03%)
GE   11.81 (-0.25%)
TSLA   510.50 (-0.58%)
AMD   50.93 (+2.33%)
T   38.38 (+0.92%)
ACB   2.13 (-0.93%)
F   9.16 (-0.11%)
NFLX   339.67 (+0.31%)
PRI   128.43 (+0.05%)
BAC   34.71 (-0.03%)
GILD   62.98 (-0.35%)
DIS   144.33 (-0.54%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
AAPL   318.73 (+1.11%)
FB   222.14 (+0.17%)
MSFT   167.10 (+0.56%)
GOOGL   1,479.52 (+2.02%)
AMZN   1,864.72 (-0.70%)
CGC   24.89 (+2.43%)
NVDA   249.28 (+0.14%)
BABA   227.43 (+1.56%)
MU   57.66 (-0.03%)
GE   11.81 (-0.25%)
TSLA   510.50 (-0.58%)
AMD   50.93 (+2.33%)
T   38.38 (+0.92%)
ACB   2.13 (-0.93%)
F   9.16 (-0.11%)
NFLX   339.67 (+0.31%)
PRI   128.43 (+0.05%)
BAC   34.71 (-0.03%)
GILD   62.98 (-0.35%)
DIS   144.33 (-0.54%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
AAPL   318.73 (+1.11%)
FB   222.14 (+0.17%)
MSFT   167.10 (+0.56%)
GOOGL   1,479.52 (+2.02%)
AMZN   1,864.72 (-0.70%)
CGC   24.89 (+2.43%)
NVDA   249.28 (+0.14%)
BABA   227.43 (+1.56%)
MU   57.66 (-0.03%)
GE   11.81 (-0.25%)
TSLA   510.50 (-0.58%)
AMD   50.93 (+2.33%)
T   38.38 (+0.92%)
ACB   2.13 (-0.93%)
F   9.16 (-0.11%)
NFLX   339.67 (+0.31%)
PRI   128.43 (+0.05%)
BAC   34.71 (-0.03%)
GILD   62.98 (-0.35%)
DIS   144.33 (-0.54%)
Log in

Intellia Therapeutics SEC Filings & 10K Form (NASDAQ:NTLA)

$14.63
-0.53 (-3.50 %)
(As of 01/17/2020 04:00 PM ET)
Today's Range
$14.61
Now: $14.63
$15.38
50-Day Range
$13.87
MA: $15.79
$17.67
52-Week Range
$10.26
Now: $14.63
$19.00
Volume684,427 shs
Average Volume616,751 shs
Market Capitalization$715.14 million
P/E RatioN/A
Dividend YieldN/A
Beta2.77

SEC Filings

Intellia Therapeutics (NASDAQ:NTLA) SEC Filings

DateFilerForm TypeView
01/09/2020
7:00 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2019
6:00 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2019
4:17 PM
Intellia Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/31/2019
6:39 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2019
4:26 PM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2019
11:15 PM
Intellia Therapeutics (Filer)
Form EFFECT
09/10/2019
10:19 AM
FMR LLC (Filed by)
Intellia Therapeutics (Subject)
Form SC 13G/A
08/30/2019
4:13 PM
Intellia Therapeutics (Filer)
Form S-3/A
08/23/2019
4:19 PM
Intellia Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/08/2019
5:02 AM
Intellia Therapeutics (Subject)
Sumitomo Mitsui Trust Holdings, Inc. (Filed by)
Form SC 13G/A
08/06/2019
1:19 PM
Intellia Therapeutics (Subject)
Nikko Asset Management Americas, Inc. (Filed by)
Form SC 13G/A
08/02/2019
3:15 PM
Intellia Therapeutics (Issuer)
SCHIERMEIER ANDREW (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2019
4:16 PM
Intellia Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2019
6:46 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/09/2019
7:53 AM
Intellia Therapeutics (Subject)
Nikko Asset Management Americas, Inc. (Filed by)
Form SC 13G
07/09/2019
5:11 AM
Intellia Therapeutics (Subject)
Sumitomo Mitsui Trust Holdings, Inc. (Filed by)
Form SC 13G
06/06/2019
11:15 PM
Intellia Therapeutics (Filer)
Form EFFECT
06/04/2019
3:16 PM
Intellia Therapeutics (Issuer)
Sepp-Lorenzino Laura (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2019
3:22 PM
Intellia Therapeutics (Issuer)
Sepp-Lorenzino Laura (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/22/2019
3:37 PM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2019
3:36 PM
Intellia Therapeutics (Issuer)
Verwiel Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2019
3:35 PM
Intellia Therapeutics (Issuer)
KARSEN PERRY A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2019
3:34 PM
GOODMAN JESSE (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2019
3:34 PM
FORMELA JEAN FRANCOIS (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2019
3:33 PM
DORSA CAROLINE (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2019
3:32 PM
Cohen Fred E (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2019
10:57 AM
Intellia Therapeutics (Filer)
Form CT ORDER
05/02/2019
4:00 PM
Intellia Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/02/2019
7:00 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2019
3:30 PM
Intellia Therapeutics (Filer)
Form DEF 14A
04/05/2019
4:26 PM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2019
1:19 PM
Caribou Biosciences, Inc. (Filed by)
Intellia Therapeutics (Subject)
Form SC 13G/A
03/12/2019
3:38 PM
Intellia Therapeutics (Issuer)
SCHIERMEIER ANDREW (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2019
2:15 PM
Intellia Therapeutics (Filer)
Form CT ORDER
03/05/2019
3:36 PM
Cohen Fred E (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2019
7:40 AM
Intellia Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/27/2019
7:37 AM
Intellia Therapeutics (Filer)
Form POS AM
02/27/2019
7:23 AM
Intellia Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/27/2019
6:58 AM
Intellia Therapeutics (Filer)
Form POSASR
02/27/2019
5:52 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2019
3:02 PM
Intellia Therapeutics (Issuer)
NOVARTIS AG (Reporting)
Novartis Institutes for BioMedical Research, Inc. (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/11/2019
2:15 PM
Intellia Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G
02/08/2019
5:02 AM
Atlas Venture Fund IX, L.P. (Filed by)
Intellia Therapeutics (Subject)
Form SC 13G/A
01/24/2019
4:31 PM
Cohen Fred E (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2019
4:29 PM
Cohen Fred E (Reporting)
Intellia Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/24/2019
6:30 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/16/2019
4:29 PM
Caribou Biosciences, Inc. (Filed by)
Intellia Therapeutics (Subject)
Form SC 13G/A
01/07/2019
7:48 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2018
3:25 PM
Intellia Therapeutics (Issuer)
Rivera Jose E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2018
3:23 PM
Intellia Therapeutics (Issuer)
SCHIERMEIER ANDREW (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2018
3:21 PM
Intellia Therapeutics (Issuer)
LEONARD JOHN M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2018
3:16 PM
Goddard Glenn (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2018
3:15 PM
Goddard Glenn (Reporting)
Intellia Therapeutics (Issuer)
Form 4/A
12/06/2018
6:45 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2018
5:37 PM
Goddard Glenn (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/31/2018
4:58 PM
GOODMAN JESSE (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/31/2018
4:57 PM
GOODMAN JESSE (Reporting)
Intellia Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/31/2018
8:01 AM
Intellia Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/31/2018
6:47 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2018
7:37 PM
Goddard Glenn (Reporting)
Intellia Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/29/2018
4:10 PM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/12/2018
4:29 PM
Intellia Therapeutics (Filer)
Form S-3ASR
08/10/2018
3:44 PM
HAYES JOHN T. (Reporting)
Intellia Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/01/2018
6:46 AM
Intellia Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2018
6:30 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/20/2018
3:31 PM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2018
7:40 AM
FORMELA JEAN FRANCOIS (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2018
3:06 PM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2018
11:03 AM
FORMELA JEAN FRANCOIS (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2018
3:15 PM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/21/2018
11:59 AM
FORMELA JEAN FRANCOIS (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2018
11:56 AM
Intellia Therapeutics (Issuer)
KARSEN PERRY A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2018
11:54 AM
DORSA CAROLINE (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2018
11:51 AM
Intellia Therapeutics (Issuer)
Verwiel Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2018
9:47 AM
FORMELA JEAN FRANCOIS (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2018
7:43 PM
Intellia Therapeutics (Issuer)
LEONARD JOHN M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2018
3:35 PM
Intellia Therapeutics (Issuer)
SCHIERMEIER ANDREW (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2018
6:46 AM
Intellia Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/01/2018
6:30 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2018
6:15 AM
Intellia Therapeutics (Filer)
Form 10-K/A
04/27/2018
3:06 PM
Intellia Therapeutics (Issuer)
SCHIERMEIER ANDREW (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/17/2018
6:30 AM
Intellia Therapeutics (Filer)
Form DEF 14A
04/17/2018
6:15 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/30/2018
9:20 AM
Bell Graeme (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2018
4:12 PM
DORSA CAROLINE (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2018
4:29 PM
Intellia Therapeutics (Issuer)
NOVARTIS AG (Reporting)
Novartis Institutes for BioMedical Research, Inc. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/23/2018
4:27 PM
Intellia Therapeutics (Subject)
Novartis Institutes for BioMedical Research, Inc. (Filed by)
Form SC 13D/A
03/22/2018
12:43 PM
FORMELA JEAN FRANCOIS (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2018
7:04 AM
Intellia Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/14/2018
6:40 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/16/2018
12:25 PM
Intellia Therapeutics (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13D/A
02/06/2018
3:07 PM
Caribou Biosciences, Inc. (Filed by)
Intellia Therapeutics (Subject)
Form SC 13G/A
01/30/2018
4:28 PM
Caribou Biosciences, Inc. (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2018
4:24 PM
Intellia Therapeutics (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13D/A
01/29/2018
2:32 PM
Intellia Therapeutics (Issuer)
LEONARD JOHN M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2018
2:31 PM
Bell Graeme (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2018
2:30 PM
Intellia Therapeutics (Issuer)
Rivera Jose E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2017
6:46 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/14/2017
3:07 PM
Bermingham Nessan (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2017
3:06 PM
Bell Graeme (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 1/17/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel